In the United States, hypertension is approximately 50% more prevalent in African Americans than Whites (41% vs. 28%). 1 African Americans also tend to develop hypertension earlier than other groups, have higher blood pressure (BP) levels, and have hypertension that is more difficult to control. 2,3 These differences in the nature of hypertension in African Americans may partly explain their disproportionate share of poor cardiovascular disease (CVD) outcomes. The 2007 US age-adjusted mortality rates due to CVD were 406 and 287 per 100,000 for African American men and women, respectively, compared to 294 and 206 per 100,000 for White men and women, respectively. 4 It has recently been noted that there are substantial racial differences in measures obtained from 24-hour ambulatory BP monitoring (ABPM), a finding that may partially explain poorer hypertension-related outcomes among African Americans. In a study of CARDIA participants, average daytime systolic BP (SBP) recorded by ABPM was higher among African Americans as compared to Whites, even after adjustment for average clinic BP. 3 Perhaps more importantly, African Americans were over 2 times more likely than Whites to have nocturnal hypertension and nondipping nocturnal BP, both of which confer increased risk of CVD. 3 Although these trends and racial differences have been demonstrated through ABPM measurements previously, we are aware of no research that has been conducted on the reproducibility of these differences. The purpose of this analysis is to examine the short-term reproducibility of several ABPM phenotypes through measurements done with both African Americans and Whites over 2 separate testing sessions.
In the United States, hypertension is approximately 50% more prevalent in African Americans than Whites (41% vs. 28%). 1 African Americans also tend to develop hypertension earlier than other groups, have higher blood pressure (BP) levels, and have hypertension that is more difficult to control. 2, 3 These differences in the nature of hypertension in African Americans may partly explain their disproportionate share of poor cardiovascular disease (CVD) outcomes. The 2007 US age-adjusted mortality rates due to CVD were 406 and 287 per 100,000 for African American men and women, respectively, compared to 294 and 206 per 100,000 for White men and women, respectively. 4 It has recently been noted that there are substantial racial differences in measures obtained from 24-hour ambulatory BP monitoring (ABPM), a finding that may partially explain poorer hypertension-related outcomes among African Americans. In a study of CARDIA participants, average daytime systolic BP (SBP) recorded by ABPM was higher among African Americans as compared to Whites, even after adjustment for average clinic BP. 3 Perhaps more importantly, African Americans were over 2 times more likely than Whites to have nocturnal hypertension and nondipping nocturnal BP, both of which confer increased risk of CVD. 3 Although these trends and racial differences have been demonstrated through ABPM measurements previously, we are aware of no research that has been conducted on the reproducibility of these differences. The purpose of this analysis is to examine the short-term reproducibility of several ABPM phenotypes through measurements done with both African Americans and Whites over 2 separate testing sessions.
METHODS
The study sample initially recruited 420 participants, the majority of whom had established care at 1 of 7 primary care clinics. Participants were recruited both from posted advertisements as well as through review of their most recent clinic BP readings via electronic medical record. Qualifying participants included those with recent office BP measurements that were recorded as 120-149 mm Hg systolic and/or as 80-95 mm Hg diastolic with neither greater than 149/95 mm 
BACKGROUND
We examined the reproducibility of differences in ambulatory blood pressure (BP) monitoring (ABPM) phenotypes and other parameters (sustained hypertension, masked hypertension, nocturnal hypertension, and nondipping) between African Americans and Whites.
METHODS
A total of 420 participants untreated for hypertension attended 2 research visits 1 week apart during which traditional office BP averages and ABPM session averages were determined. We computed percent agreement in ABPM phenotypes across the 2 visits stratified by race and associated kappa statistics with 95% confidence intervals.
RESULTS
Whites on average were older, more likely to be male, and had a higher body mass index. There was no significant difference in sleep quality as defined by sleep diary between the 2 races. There were also no significant differences between races in the proportions of participants with sustained hypertension, sustained normotension, or masked hypertension at either testing session. The prevalence of nocturnal hypertension was 59% vs. 75% (P = 0.012) at session 1 and 59% vs. 73% (P = 0.024) at session 2 for Whites and African Americans, respectively, with moderate reproducibility for both (kappas 0.45 and 0.44). Nocturnal BP nondipping had a prevalence 29% vs. 53% (P < 0.001) at session 1 and 29% vs. 47% (P = 0.004) at session 2 for Whites and African Americans, respectively, with fair reproducibility (kappas 0.28 and 0.29).
Hg. Furthermore, participants with SBPs <110 mm Hg or >159 mm Hg or with diastolic BPs (DBPs) <71 mm Hg or >99 mm Hg on their initial visit were excluded. Additional qualifications required an individual to be at least 30 years of age, have a dedicated primary care physician, and currently be on no antihypertensive medication. Any potential participant with dementia, pregnancy, persistent atrial fibrillation or other arrhythmia, or a condition prohibiting placement of an ambulatory BP monitor was excluded from enrollment.
OFFICE BP MEASUREMENTS
At each of 2 research visits 1 week apart, individuals were placed in an exam room and allowed to rest for 5 minutes before measurements began. Three BP measurements were then taken on the nondominant arm using a validated clinic oscillometric device (Welch Allyn Vital Signs) with an appropriate cuff size. BP cuff size was determined by midbicep circumference measurements. The second and third measurements were averaged to determine the office BP for the research visit (office SBP and office DBP).
OTHER MEASUREMENTS
Height and weight were measured and used to calculate body mass index. A questionnaire was used to collect demographic and social history data (e.g., work, alcohol, and tobacco use). Cholesterol was measured by serum sample.
AMBULATORY BP MONITORING
At the conclusion of the initial visit and 1 week later, an Oscar 2 Oscillometric monitor (Suntech Medical, Morrisville, NC) was used to record 24-hour ambulatory BP measurements. The Oscar 2 monitor has undergone independent validation by the International Protocol for the validation of BP measuring devices and the British Hypertension Society. 5, 6 The monitors were programmed to record BP measurements every 30 minutes between 6 am and 10 pm and every hour between 10 pm and 6 am. The measurement interval is slightly more relaxed than the standard ABPM intervals, as the protocol was selected keeping in mind the burden of asking participants to wear the monitor on 2 occasions 1 week apart. The monitors acquired individual readings within 140 seconds of measurement initiation and did not exceed a pressure greater than 220 mm Hg. For individuals 1-143, or those prior to the incorporation of a sleep diary, the awake period was defined as 10 am-10 pm, and the nocturnal, or sleep period, as 12 am to 6 am. 7 For the remaining 144-420 participants, a sleep diary was used to define these corresponding time intervals. Sleep quality was measured by self-reported quality for the previous night using a 5-point scale ranging from 1 to 5 with 1 representing poor sleep and 5 representing good sleep. For an ABPM session to be valid for interpretation, 14 daytime measurements and 6 nocturnal measurements were required. Participants were instructed on the importance of keeping the cuff correctly positioned on the arm during a reading so that an accurate measurement could be recorded. They were also informed that they would experience a momentary tightness associated with the pressure cuff during measurement and that any measurement errors would trigger a repeated automated measurement.
ABPM PHENOTYPE DEFINITIONS
Mean SBP and DBP were calculated for both daytime and nocturnal periods in the ABPM data. Elevated ABPM daytime pressure was defined as a mean SBP ≥135 mm Hg or mean DBP ≥85 mm Hg and elevated office BP as a mean SBP ≥140 mm Hg or mean DBP ≥90 mm Hg. 8 The ABPM data were paired with the office BP averages from the corresponding placement visit in order to ascertain phenotypes. Sustained awake normotension was defined as both a nonelevated mean daytime ABPM average with a nonelevated office BP average. Sustained 24-hour normotension was defined as a nonelevated 24-hour ABPM average with a nonelevated office BP average. Masked awake hypertension was defined as an elevated daytime ABPM average without elevated office values. Masked 24-hour hypertension referred to elevated 24-hour ABPM averages without any elevated office values. Sustained awake hypertension was defined as both an elevated daytime ABPM average and office BP. Sustained 24-hour hypertension was defined as a 24-hour elevated ABPM average and office BP.
Other measures were based solely on ABPM data. Nocturnal hypertension was defined as a nocturnal mean SBP ≥120 mm Hg or DBP ≥70 mm Hg. Nocturnal BP dipping was based on the mean nighttime-to-daytime SBP ratio. If this value was ≥0.090, the participant was considered a nondipper. Morning surge was defined as the mean SBP from 7 am to 9 am after waking minus the nighttime trough BP. 3 The systolic day-night SD mean was the weighted mean of daytime and nighttime systolic SD measurements. 3 The same was applied to diastolic measurements. The average real variability (ARV) reflected the average absolute difference in successive readings within the ABPM period. This analysis was performed for both systolic and diastolic pressures.
STATISTICAL ANALYSIS
Demographic characteristics, office SBP, and office DBP were compared between races using t-tests and chi-square tests as applicable. From the ABPM data, mean daytime SBP and DBP, nighttime SBP and DBP, systolic and diastolic ARV, dipping ratio, systolic and diastolic morning surge, and systolic and diastolic day-night SD mean were also compared between races using t-tests. The proportions of participants with each version (awake or 24-hour) of sustained hypertension, each version of sustained normotension, each version of masked hypertension, nocturnal hypertension, and nocturnal BP nondipping were determined and differences were tested using chi-square. We did not include white-coat hypertension in the analyses because of the low prevalence in this sample. Differences between races were further characterized using multivariate adjustments using linear or logistic regression as appropriate. Adjustment 1 was based on age and sex. Adjustment 2 was based on age, sex, smoking status, alcohol use, and body mass index, and sleep quality. Percent agreements between the first and second sessions were assessed. Agreement was quantified using the kappa statistic, its 95% confidence interval and P value. 9 Kappa statistics were calculated based on the agreement between the binary outcomes of whether or not a subject had a particular phenotype between sessions.
RESULTS
Of the 420 recruited participants, only 16 were excluded because they were neither White nor African American. The mean age of Whites and African Americans was 49.1 (SD 12.2) and 43.7 (SD 10.0), respectively ( Table 1) . As compared to Whites, African Americans had a higher body mass index, arm circumference, and alcohol consumption level. Whites had higher mean total cholesterol values. Office SBP and DBP at both sessions were not statistically different between African Americans and Whites. Mean ambulatory daytime SBP was slightly higher in the White population for session 1 after adjustment for age, sex, smoking, alcohol use, and body mass index. Mean nighttime SBP was significantly higher in African Americans at the initial session, and mean nighttime DBP was significantly higher in African Americans at both sessions, though mitigated by adjustment in the second model in the second session (Table 2) .
There were no statistical differences between races in the proportions of participants with sustained hypertension, sustained normotension, or masked hypertension at either testing session (Table 3) . Differences in nocturnal hypertension, however, were statistically significant and reproducible across race at both testing sessions. At session 1, the prevalence of nocturnal hypertension was 59% vs. 75% (P = 0.012) for Whites and African Americans, respectively, and at session 2, this difference was 59% vs. 73% (P = 0.024). For Whites, this agreement was 74% concordant with a kappa value of 0.45 (95% CI 0.34-0.56) indicative of moderate reproducibility. 9 For African Americans, this agreement was 79% concordant with a kappa value of 0.44 (95% CI 0.19-0.70) also indicative of moderate reproducibility. Intraclass correlation coefficients and associated scatterplots show modest agreement between sessions and are shown in Supplementary Table 3 and Figures 1-4 , respectively. Twoby-two tables representing the concordance and discordance between ABPM phenotypes are shown in Supplementary  Table 4 .
The mean nocturnal BP dipping ratio was also statistically significant across race at both testing sessions as well (Table 4) . At session 1, the ratios were 0.86 and 0.91 (P < 0.001) for Whites and African Americans, respectively, and 0.86 and 0.90 (P < 0.001) at session 2. Nocturnal BP nondipping was also statistically significant and reproducible across race at both testing sessions. The prevalence of nondipping was 29% vs. 53% (P < 0.001) at session 1 for Whites and African Americans, respectively, and 29% vs. 47% (P = 0.004) at session 2. For Whites, this agreement Numbers are mean (SD) or percentage, alcohol consumption was based on consumption of 5 or more drinks in the past 30 days via survey, sleep quality was rated on a scale of 1-5 with 1 being hardly any sleep and 5 being good sleep also via survey. Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.
was 70% concordant with a kappa value of 0.28 (95% CI 0.15-0.40), indicating fair reproducibility. For African Americans, this agreement was 64% concordant with a kappa value of 0.29 (95% CI 0.05-0.53), also indicating fair reproducibility.
The systolic component of the morning surge phenomenon was also statistically significant across race at both testing sessions. At session 1, the morning surge was 32.1 vs. 24.9 mm Hg (P < 0.001) for Whites vs. African Americans, respectively. At session 2, this difference was 32.5 vs. 26.9 mm Hg (P = 0.002). A final analysis was performed on the ARV in ABPM measurements. For both sessions, there was no statistical difference in systolic ARV across race at both sessions (Supplementary Table) . However, statistical differences in diastolic ARV did exist. The diastolic ARV at session 1 was 8.8 vs. 9.4 (P = 0.04) for Whites and African Americans, respectively, and 8.7 vs. 9.5 (P = 0.02) at session 2.
DISCUSSION
In this analysis, several BP phenotypes and ABPM parameters were examined across race for reproducibility at 2 separate testing sessions. Of the phenotypes examined, African Americans exhibited a greater preponderance of abnormal nocturnal BP patterns that were modestly reproducible. The occurrence of nocturnal hypertension, higher mean dipping ratios, and overtly higher rates of BP nondipping indicate that African Americans are more likely to have abnormalities in their nighttime pressures than Whites. This finding is consistent with prior studies that have demonstrated that African Americans have higher rates of nocturnal hypertension. 3, 10 This finding is also consistent with a meta-analysis that showed that African Americans have both higher daytime and nighttime pressures than Whites, but that the difference in nighttime pressures is much greater. 11 The findings presented here are significant because nocturnal hypertension portends increased risk of cardiovascular, noncardiovascular, and all-cause mortality. [12] [13] [14] A comprehensive review of approximately 24,000 hypertensive patients showed that elevated nighttime BPs increases the risk of CVD and all-cause mortality even after controlling for daytime pressures. 15 As such, nighttime readings have been shown to add prognostic value to preexisting daytime measurements; however, the reverse scenario in which daytime values added precision to nighttime ones was not true. 16 This finding was confirmed by Boggia et al., who also determined that elevated nighttime pressures predicted fatal events more accurately than elevated daytime pressures. 14 Ben-Dov also showed that nighttime pressures better determined risk for all-cause mortality. 17 Both elevated nocturnal systolic and diastolic pressures predicted fatal and nonfatal stroke events as well. 14, 16 Nocturnal BP nondipping and abnormal mean dipping ratios were 2 modestly reproducible phenotypes in African Americans in this study. The former refers to the absence of an appropriate dip in nighttime BP with the latter representing the nighttime-daytime SBP ratio. Typically, decreases in BP at night range from 10% to 20% from the daytime baseline, and less pronounced BP can pose important risks to health. 13 As in nocturnal hypertension, night-to-day ratios also predict cardiovascular, noncardiovascular, and allcause mortality. 14, 15 These relationships were shown to exist even after adjustments for 24-hour BP levels. 15, 17 In resistant hypertension, nocturnal BP nondipping was found to double one's risk of CVD in comparison to normal dipping rates. 18 In fact, for each 5% loss in nocturnal BP decline, cardiovascular mortality increased up to 20%, suggesting that the degree of BP decline is an important risk factor as well. 14, 16 Nondipping status is also associated with structural heart disease. Left ventricular hypertrophy, for example, is present more commonly in nondippers than dippers. 19, 20 Lastly, nondipping is related to stroke, with silent cerebral infarction being more common in nondippers. 19, 20 Diastolic ARV was also higher in African Americans at both sessions. Hansen et al. showed that BP variability was indeed an independent predictor for cardiovascular and stroke events with ARV being a better predictor than even the day-night SD mean SD DN . 21 However, the risk attributable to this variable was low in regard to other pressure phenotypes. Hansen also determined that diastolic ARV was a stronger predictor of cardiovascular and stroke events than systolic ARV possibly due to increases in arterial stiffness that alter DBPs more so than the systolic ones. 21 The strength of DBP variability was confirmed by Boggia et al., who showed that after multivariate adjustment which included 24-hour SBP, diastolic ARV predicted cardiovascular mortality. 22 An unexpected finding in our sample was the higher mean systolic daytime ABPM pressure in Whites, although this difference was weakly significant at best. A recent study comparing African Americans and Whites (mean age 30 years) found that mean SBP on ABPM was higher among African Americans. 3 The reasons for these differences in our study may have to do with the older age of our sample population.
Several explanations could account for the prevalence of nighttime BP abnormalities in African Americans. It has been shown that falling asleep is associated with a dampening of the sympathetic nervous system, as epinephrine levels are known to be at their lowest levels during sleep. 23 It is possible that this normal response was reduced in African Americans, resulting in elevated nocturnal pressures. Another explanation pertains to sodium sensitivity and resulting changes in BP associated with varying levels of sodium intake. One study showed that in people with essential hypertension who were sensitive to sodium intake, BPs did not fall at night. 24 This finding is supported by Harshfield's findings that African Americans may have abnormal levels of sodium excretion, suggesting that many of them could display sodium sensitivity. 25 Obstructive sleep apnea is also a well-established independent risk factor for hypertension and is a commonly underdiagnosed comorbidity. 26 It is possible that its prevalence in the African American population is disproportionately high and that more thorough surveillance is needed to capture incidence rates.
Our analysis had some limitations. Our sample was generally healthy, and so our findings may not be perfectly representative of a general clinic population or the larger populations of African Americans and Whites. We recruited patients whose recent primary care office BP was in what was defined as the borderline range. The targeting of such patients may explain the low proportion that had white-coat hypertension. It may also explain the high prevalence of masked hypertension in this cohort due to the high pretest probability of masked hypertension among patients seen in the office with BPs in the prehypertension range. Our findings were similar to those of Shimbo, who found a prevalence of masked hypertension of 34% among a community sample of adults with prehypertension. 27 Among a subset of this population with SBPs in the 130-139 mm Hg range and DBPs in the 85-89 mm Hg range, the prevalence of masked hypertension was 52%, providing additional evidence for the high pretest probability of masked hypertension among people with BP in the upper prehypertension range. 27 It is also important to note that the reproducibility of our nocturnal BP patterns was modest at best and that some may regard kappas <0.4 as poor reproducibility. Though this analysis had some limitations, the significant and reproducible differences in ABPM measures between African Americans and Whites are of importance. Further analyses, including large population-based studies, should aim to investigate whether the differences in ABPM profiles and ABPM phenotypes could help to explain much of the difference in CVD outcomes between African Americans and Whites.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of Hypertension online.
